Intravenous ibandronate (Boniva).
D000284:Administration, Oral; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D004164:Diphosphonates / Q000008:administration & dosage* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D017277:Drug Approval; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D007275:Injections, Intravenous; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077557:Ibandronic Acid